Cargando…
Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
For families with a small number of cases of breast and/or ovarian cancer, limited data are available to predict the likelihood of genetic predisposition due to mutations in BRCA1 or BRCA2. In 104 families with three or more affected individuals (average 3.8) seeking counselling at family cancer cli...
Autores principales: | Ligtenberg, M J L, Hogervorst, F B L, Willems, H W, Arts, P J W, Brink, G, Hageman, S, Bosgoed, E A J, Looij, E Van der, Rookus, M A, Devilee, P, Vos, E M A W, Wigbout, G, Struycken, P M, Menko, F H, Rutgers, E J Th, Hoefsloot, E H, Mariman, E C M, Brunner, H G, Veer, L J Van't |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362698/ https://www.ncbi.nlm.nih.gov/pubmed/10188893 http://dx.doi.org/10.1038/sj.bjc.6690235 |
Ejemplares similares
-
Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
por: van Sprundel, T C, et al.
Publicado: (2005) -
Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up
por: Olivier, R I, et al.
Publicado: (2004) -
HIF-1α Overexpression in Ductal Carcinoma In Situ of the Breast in BRCA1 and BRCA2 Mutation Carriers
por: van der Groep, Petra, et al.
Publicado: (2013) -
Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2, and RAD51C Status
por: Cunningham, J. M., et al.
Publicado: (2014) -
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
por: Heemskerk-Gerritsen, Bernadette A. M., et al.
Publicado: (2019)